Skip to main content

Simple (Benign) Nephrectomy

Simple nephrectomy generally refers to removal of a kidney for benign disease, without a planned oncologic lymphadenectomy or routine adrenalectomy. The dissection plane and amount of surrounding tissue removed depend on inflammation and operative safety. The BAUS Nephrectomy Database authors propose the more accurate term "benign nephrectomy", because inflammation and fibrosis can make the operation technically demanding, with higher complication or conversion rates than T1 radical nephrectomy in some cohorts.[1][2][3]

A benign nephrectomy is not defined by always remaining inside Gerota's fascia. Severe inflammation may require an extrafascial or subcapsular plane; an outside-Gerota approach has been described specifically for inflammatory kidneys. Preserve adjacent organs and choose the safest identifiable plane.[27][1][3][2]

Indications​

Non-functioning kidney (most common)​

Very low split renal function is sometimes labeled non-functioning, but a scan cutoff alone does not establish irreversibility or mandate nephrectomy. The cited pediatric PUJO cohort began with split function below 10% and reported recovery after drainage followed by pyeloplasty in all 15 selected children; this supports assessing salvageability, not a universal nephrectomy threshold.[4] Etiologies in large series:[5][1]

  • Ureteropelvic junction obstruction — single most common cause (39% of Gupta n = 505).
  • Calculus disease — 38%.
  • Chronic pyelonephritis / pyonephrosis.
  • Vesicoureteral reflux with reflux nephropathy.
  • Genitourinary tuberculosis — 9.5%.
  • Renal dysplasia / anomalous kidney.

In the UK BAUS series (n = 1,093), non-functioning kidneys accounted for 49%, other benign conditions 26%, stone disease 13%, and pyelonephritis 12%.[1]

Stone disease​

Indicated when stone disease has caused irreversible parenchymal damage with non-function — staghorn calculi with chronic infection, recurrent stone formation in a non-functioning kidney, or failed prior interventions.

Stone disease carries the highest complication rate of any benign indication: intraoperative complications 9.9% and postoperative 23.9%.[1]

In a safety-net hospital series, stone disease was the leading medical contributor (55.3%), followed by retained ureteral stent (30.6%) and stricture (30.6%). The operating surgeon judged 38.8% of cases preventable had the underlying conditions been addressed earlier.[7]

Xanthogranulomatous pyelonephritis (XGP)​

Destructive chronic pyelonephritis with replacement of parenchyma by lipid-laden xanthoma cells. Systematic review of >1,000 cases:[8][9]

  • Mean age 49; 70% female; 28% diabetic.
  • 69% have stones (48% staghorn).
  • Correctly diagnosed preoperatively only 45% of the time — frequently mistaken for renal neoplasm.
  • Fistulae in 8%.
  • Total nephrectomy is usual for diffuse destructive XGP; partial nephrectomy was performed in 2% of the reviewed patients. That utilization rate is not the proportion anatomically eligible for partial surgery.
  • Perioperative mortality 1.4%.

In a 61-patient retrospective multicenter cohort, ≥28 days of preoperative antibiotics was associated with 6.5 days shorter stay and fewer complications among laparoscopic cases after adjustment for drainage. This does not establish a mandatory course or justify delaying urgent source control.[10]

Renovascular hypertension​

Selected patients with renal artery stenosis who develop a small atrophic non-functioning kidney contributing to treatment-resistant hypertension after revascularization failure. Mayo Clinic n = 74, mean follow-up 4.1 years (mean long axis 8 cm, mean function 12%):[11]

  • Systolic BP fell from 168 to 136 mmHg (p < 0.001).
  • Cure or improvement of hypertension in the majority.
  • Two-thirds of hypertensive patients with severe unilateral disease benefited.

Genitourinary tuberculosis​

Treat GU tuberculosis with appropriate combination antituberculous therapy. Nephrectomy may be considered for an unsalvageable symptomatic kidney or other specific complications; the older series do not establish a universal minimum six-week delay.[12][13][14]

In the landmark Skutil/Obsitník series of 300 GU TB patients, 21.7% required nephrectomy. The most common indication was persistent tuberculous cystitis (62%), followed by chronic infection/calcification (13.1%) and suspected nephrogenic hypertension (11.7%); two-thirds of hypertensive patients benefited from nephrectomy.[13][15]

Current EAU guidance states that the optimal timing and surgical approach remain uncertain and decisions should be individualized according to disease extent and damage. Timing should be agreed with the TB team; urgent drainage or source control must not be deferred to satisfy an arbitrary waiting period.[36]

Autosomal dominant polycystic kidney disease (ADPKD)​

Per KDIGO 2025, native nephrectomy in ADPKD is performed only for specific indications when benefit outweighs risk:[16][17][18][19]

  • Severe symptoms from massively enlarged kidneys (mass effect).
  • Recurrent or severe infection or bleeding.
  • Complicated nephrolithiasis.
  • Intractable pain.
  • Suspicion of renal cell carcinoma.
  • Insufficient space for a kidney graft.
  • Severe ventral hernia.

Key principles:

  • At or after transplantation whenever possible — KDIGO recommendation 3.2.3 is conditional (2C), not an absolute prohibition on pretransplant surgery. Individualize timing for infection, bleeding, graft space, donor availability and other indications.
  • Hand-assisted laparoscopic nephrectomy when feasible is suggested over open (KDIGO 2D), with approach selected by anatomy and expertise.
  • Up to ~20% of ADPKD patients eventually require nephrectomy.
  • ERA 2025 consensus confirms nephrectomy is an intermediate-risk procedure with acceptable mortality and minimal impact on graft function.

Other benign indications​

  • Chronic pain from a non-functioning kidney.
  • Recurrent UTI from a non-functioning kidney serving as an infection nidus.
  • Failed prior reconstruction (e.g., failed pyeloplasty).
  • Renal hypoplasia / dysplasia.
  • Multicystic dysplastic kidney (when symptomatic).
  • Iatrogenic ureteral injury producing a non-functioning kidney.[3][5]

Surgical Approaches​

Open simple nephrectomy​

Appropriate when exposure, inflammatory burden, vascular anatomy, kidney size or team expertise favor it; planned open surgery need not follow a failed minimally invasive attempt.

Flank (retroperitoneal) approach.

  • Lateral decubitus, affected side up.
  • Incision over the 11th or 12th rib, posterior axillary line to anterior axillary line.
  • Divide external oblique, internal oblique, transversus abdominis.
  • Select the safe plane according to inflammation; this may be intrafascial, extrafascial or subcapsular.
  • Identify the hilum; ligate and divide renal artery and vein individually.
  • Manage the ureter according to the indication and stump risks; do not add unnecessary distal dissection solely for maximal length.
  • Direct retroperitoneal access without entering the peritoneum or manipulating bowel.
  • The posterior lumbotomy (Novick) is excellent for bilateral nephrectomy, simple nephrectomy for benign disease, and pyeloplasty.[20]

Transperitoneal (anterior subcostal) approach. Wider exposure for larger kidneys or when additional abdominal exploration is needed; requires bowel mobilization.[21]

In the Gupta retrospective series, open cases had shorter mean operative time (70 vs 85 min), greater blood loss (170 vs 110 mL), and longer stay (5 vs 3 days). Selection differences limit generalizing this comparison.[5]

Laparoscopic simple nephrectomy​

A commonly used approach for appropriately selected benign nephrectomy — 76% were laparoscopic in the historical UK BAUS database.[1]

Transperitoneal. Lateral decubitus; 3–4 ports along anterior axillary and midclavicular lines; reflect colon medially (Toldt); control hilum with clips, staples, or sutures; retrieve the specimen in a bag through a suitable incision. Morcellation requires careful exclusion of suspected malignancy and a deliberate plan for pathological assessment.

Retroperitoneal. Lateral decubitus or prone; balloon-dilate the retroperitoneal space; 3 posterior ports; direct hilar access without bowel mobilization. Particularly useful for inflammatory kidneys (avoids peritoneal contamination) and patients with prior abdominal surgery.[22][5]

The largest retroperitoneoscopic series (Gupta n = 505):[5]

  • The abstract reports 476/505 (94.2%) completed retroperitoneoscopically and 25 conversions; it does not explain the remaining 4 cases.
  • Mean OR time 85 min; mean blood loss 110 mL.
  • Transfusion rate 0.8% (vs 4.5% open).
  • Mean LOS 3 d (vs 5 d open).

Robotic simple nephrectomy​

Robotic nephrectomy is feasible. The Rogers report included 42 patients with mixed benign and malignant indications; its mean console time of 158 minutes and stay of 2.4 days should not be attributed to the 7 benign cases alone.[23] A lower conversion rate than conventional laparoscopy for infected kidneys has not been established by that series.

Subcapsular nephrectomy​

When severe perirenal inflammation makes extracapsular dissection hazardous (XGP, pyonephrosis, TB), the renal capsule is incised and the kidney dissected within the capsule, leaving the capsule adherent to surrounding structures. Hilar vessels are controlled from within the capsule. Used in 6/52 (11.5%) pyonephrotic kidneys in one series.[24][25][26]

Why Benign Nephrectomy Is Harder Than Radical​

ParameterSimple (Benign)Radical (T1 Cancer)
Intraoperative complications5.2%3.7%
Postoperative complications11.9%10.0%
Conversion to open (MIS)5.9% (1.8× higher)3.3%
Blood transfusion4.8%2.8%
Operative timeLonger (p = 0.001)Shorter
Length of stayLonger (p = 0.049)Shorter

References:[1][2]

The reasons are anatomic, not oncologic:[1][3][2][27]

  1. Perirenal fibrosis and adhesions from chronic inflammation obliterate tissue planes.
  2. Hilar lymphadenopathy obscures vascular anatomy.
  3. Pyonephrosis / abscess raises contamination and sepsis risk.
  4. Prior surgery / nephrostomy introduces dense scarring.
  5. Loss of the Gerota's-fascia plane that makes the radical operation predictable.

Infected simple nephrectomies are particularly demanding (significantly increased OR time, blood loss, conversion rate, and LOS).[2] Duarte et al. reported 14/50 conversions (28%) across a mixed inflammatory-kidney cohort, not a 28% XGP-specific conversion rate. These complex cases require explicit conversion and organ-injury counseling.[27][28]

Complications​

Overall (BAUS n = 1,093):[1]

  • Intraoperative 5.2%; postoperative 11.9%; blood loss >500 mL 6.8%; transfusion 4.8%; MIS conversion 5.9%.

By pathology:[1]

PathologyIntraoperativePostoperative
Stone disease9.9%23.9%
Pyelonephritis5.4%14.0%
Non-functioning kidney4.3%9.3%
Other benign4.6%9.5%

Specific complications to anticipate:[27][21][29][3][28]

  • Vascular injury — renal vein or IVC injury, particularly on the right side with inflammatory hilar adhesions; the most feared intraoperative complication.
  • Visceral injury — colonic (more common laparoscopically), splenic (left), duodenal (right).
  • Pleural entry — more common with the open flank approach.
  • Wound complications — flank bulge ~4%, hernia, wound infection.
  • Postoperative bleeding — may require transfusion or re-exploration.
  • Ileus — particularly with the transperitoneal approach.

Emergency nephrectomy for surgical pyelonephritis​

In a recent series of 88 patients with surgical pyelonephritis (pyonephrosis, renal/perinephric abscess, emphysematous pyelonephritis), 10 underwent primary emergency nephrectomy and 9 required secondary nephrectomy after failed conservative management. Diabetes, high ASA score, CKD, and smoking were associated with conservative-management failure.[30]

Long-Term Renal Function​

Simple nephrectomy is functionally different from radical nephrectomy because the kidney being removed is usually already non-functioning and the contralateral kidney has had time to compensate.[31]

  • GFR decline after simple nephrectomy: 6% vs radical nephrectomy: 29% (p < 0.001).
  • Postoperative GFR is significantly higher after simple nephrectomy at all time points (1 d, 1 mo, 1 yr, last follow-up).
  • Mechanism: gradual functional loss of the diseased kidney drives compensatory hypertrophy of the contralateral kidney before surgery.

Older reduced-renal-mass literature describes compensatory changes after nephrectomy, but it should not be used to promise absence of progressive kidney disease in a patient with benign urologic disease. Baseline contralateral function, proteinuria, blood pressure, diabetes and other CKD risks determine ongoing surveillance needs.[32]

Preoperative Optimization​

For inflammatory or infected kidneys:[5][10][12][13][14][33][4]

  • Percutaneous nephrostomy to drain pyonephrosis or obstructed infected systems before definitive nephrectomy. 33/36 pyonephrotic patients had preoperative PCN in the Gupta series.
  • Culture-directed antibiotics and drainage for XGP; duration depends on infection control and planned surgery. A ≥4-week association in a retrospective cohort is not a mandatory waiting rule.
  • Coordinate renal TB therapy and surgery with specialists; current EAU guidance does not establish a fixed six-week surgical threshold.[36]
  • CT with contrast to map perirenal inflammation, hilar anatomy, adjacent organ involvement, vascular anomalies.
  • Nuclear renography to assess differential function and drainage; consider recoverability and possible reconstruction before nephrectomy.

For ADPKD:[16]

  • Cross-sectional imaging within 1 year of anticipated transplantation to rule out solid or complex cystic lesions.
  • Subtract estimated total kidney and liver weights from body weight for accurate BMI assessment.

Approach Selection​

Clinical scenarioPreferred approachRationale
Elective non-inflammatory NFKRetroperitoneoscopic or laparoscopicCommonly used when anatomy and expertise are suitable.[1][2]
Inflammatory kidney (XGP, pyonephrosis)Retroperitoneoscopic (experienced surgeon) or openAvoids peritoneal contamination; low threshold for conversion.[3][27]
Prior ipsilateral surgery / nephrostomyIndividualize accessThe retroperitoneum itself may be scarred; map prior incisions, drainage tracts and inflammatory planes.[5]
ADPKD (massively enlarged)Hand-assisted laparoscopicAllows specimen extraction; handles large kidneys.[16][19]
Renal TBIndividualized access and timing with TB treatmentSubcapsular if severe adhesions.[12][25]
Emergency (sepsis, emphysematous PN)Open (often)Speed and safety; high MIS-conversion rate.[30]
PediatricMIS (any approach)Approach depends on anatomy, size and expertise; comparative studies are observational.[34]

Special Populations​

Pediatric​

Minimally invasive nephrectomy is commonly used in suitable pediatric cases. In a 213-nephrectomy comparison (single-instrument retroperitoneoscopic, two-instrument retroperitoneoscopic, transperitoneal, and open), MIS approaches had significantly fewer intraoperative complications (p = 0.03) with comparable OR time and LOS. No conversions occurred in the retroperitoneoscopic groups.[34]

Elderly​

In a 20-year series of 646 consecutive nephrectomies, nephrectomy for benign conditions had a significantly lower complication rate than for malignant disease (p < 0.05), and laparoscopic approaches had lower morbidity than open in elderly cohorts.[35]

Social determinants​

In a safety-net hospital series, social factors contributing to simple nephrectomy included lack of insurance (58.5%), substance abuse (32.3%), mental health (24.6%), and immigration status (18.5%). The authors framed simple nephrectomy as potentially representing a "failure of management" of underlying conditions — awareness can guide prevention strategies.[7]

Outcomes Summary​

SeriesnApproachOR timeEBLConversionLOSComplications
BAUS UK 2016[1]1,09376% MISNR>500 mL in 6.8%5.9%NR5.2% intra / 11.9% post
Gupta 2008[5]505Retroperitoneoscopic85 min110 mL5.0%3 d0.8% transfusion
Hemal 2001[24]185Retroperitoneoscopic100 min133 mL9.7%3 d16.2% minor / 3.8% major
Papadopoulou 2024[2]129MixedLonger than RNSimilarSimilarLonger than RNHigher than RN
Hsiao 2008[3]42Laparoscopic202.5 min100 mL7.1%Variable21.4%
Parra 1995[6]12Laparoscopic145 minNR8.3%3.5 d16.7%

See Also​

References​

1. Zelhof B, McIntyre IG, Fowler SM, et al. Nephrectomy for benign disease in the UK: results from the British Association of Urological Surgeons Nephrectomy Database. BJU Int. 2016;117(1):138–144. doi:10.1111/bju.13141

2. Papadopoulou A, Campain N, Abu-Ghanem Y, et al. Not-so-simple nephrectomy: comparative analysis of radical and simple nephrectomy in a high-volume tertiary referral center. Int J Urol. 2024;31(2):160–168. doi:10.1111/iju.15330

3. Hsiao W, Pattaras JG. Not so "simple" laparoscopic nephrectomy: outcomes and complications of a 7-year experience. J Endourol. 2008;22(10):2285–2290. doi:10.1089/end.2008.9718

4. Rai RK, Pandey A, Verma S, et al. Management of non-functioning kidney due to pelvi-ureteric junction obstruction in pediatric age group: an observational study. Pediatr Surg Int. 2023;39(1):85. doi:10.1007/s00383-023-05368-3

5. Gupta NP, Hemal AK, Mishra S, Dogra PN, Kumar R. Outcome of retroperitoneoscopic nephrectomy for benign nonfunctioning kidney: a single-center experience. J Endourol. 2008;22(4):693–698. doi:10.1089/end.2007.0267

6. Parra RO, Perez MG, Boullier JA, Cummings JM. Comparison between standard flank versus laparoscopic nephrectomy for benign renal disease. J Urol. 1995;153(4):1171–1173; discussion 1173–1174.

7. Ames KS, Baky F, Blair S, et al. Simple nephrectomy in a tertiary care safety net hospital — patient characteristics, causes, cost, and renal function implications. Urology. 2021;149:98–102. doi:10.1016/j.urology.2020.12.013

8. Harley F, Wei G, O'Callaghan M, et al. Xanthogranulomatous pyelonephritis: a systematic review of treatment and mortality in more than 1000 cases. BJU Int. 2023;131(4):395–407. doi:10.1111/bju.15878

9. Jang TL, McKoy T, Hakim J, Polenakovik HM. Xanthogranulomatous pyelonephritis — a diagnostic and therapeutic dilemma. Am J Med Sci. 2023;365(3):294–301. doi:10.1016/j.amjms.2022.11.004

10. Xie L, Tapiero S, Flores AR, et al. Long-term antibiotic treatment prior to laparoscopic nephrectomy for xanthogranulomatous pyelonephritis improves postoperative outcomes: results from a multicenter study. J Urol. 2021;205(3):820–825. doi:10.1097/JU.0000000000001429

11. Kane GC, Textor SC, Schirger A, Garovic VD. Revisiting the role of nephrectomy for advanced renovascular disease. Am J Med. 2003;114(9):729–735. doi:10.1016/s0002-9343(03)00161-x

12. Nahid P, Dorman SE, Alipanah N, et al. Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of drug-susceptible tuberculosis. Clin Infect Dis. 2016;63(7):e147–e195. doi:10.1093/cid/ciw376

13. Flechner SM, Gow JG. Role of nephrectomy in the treatment of non-functioning or very poorly functioning unilateral tuberculous kidney. J Urol. 1980;123(6):822–825. doi:10.1016/s0022-5347(17)56149-2

14. Carl P, Stark L. Indications for surgical management of genitourinary tuberculosis. World J Surg. 1997;21(5):505–510. doi:10.1007/pl00012277

15. Skutil V, Obsitník M. Persistent tuberculous cystitis: the most common indication for nephrectomy in the management of urogenital tuberculosis. Eur Urol. 1987;13(1–2):57–61.

16. Torres VE, Ahn C, Barten TRM, et al. KDIGO 2025 Clinical Practice Guideline for the Evaluation, Management, and Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD): Executive Summary. Kidney Int. 2025;107(2):234–254. doi:10.1016/j.kint.2024.07.010

17. Geertsema P, Gansevoort RT, Arici M, et al. Nephrectomy in autosomal dominant polycystic kidney disease: a consensus statement of the ERA Genes & Kidney Working Group. Nephrol Dial Transplant. 2025;40(5):1032–1054. doi:10.1093/ndt/gfaf019

18. Ong ACM, Carriazo S, Ma BM, Torra R, Pei Y. Autosomal dominant polycystic kidney disease. Lancet. 2026;407(10535):1289–1302. doi:10.1016/S0140-6736(26)00046-2

19. Thomas MN, Datta RR, Wahba R, et al. Introduction of laparoscopic nephrectomy for autosomal dominant polycystic kidney disease as the standard procedure. Langenbecks Arch Surg. 2023;408(1):8. doi:10.1007/s00423-022-02737-9

20. Novick AC. Posterior surgical approach to the kidney and ureter. J Urol. 1980;124(2):192–195. doi:10.1016/s0022-5347(17)55369-0

21. Anastasiou J, Karatzas T, Felekouras E, et al. Radical nephrectomy with transperitoneal subcostal incision for large and locally advanced tumors of the right kidney. Anticancer Res. 2012;32(11):5023–5029.

22. Gupta NP, Goel R, Hemal AK, et al. Should retroperitoneoscopic nephrectomy be the standard of care for benign nonfunctioning kidneys? An outcome analysis based on experience with 449 cases in a 5-year period. J Urol. 2004;172(4 Pt 1):1411–1413. doi:10.1097/01.ju.0000138371.46317.7a

23. Rogers C, Laungani R, Krane LS, et al. Robotic nephrectomy for the treatment of benign and malignant disease. BJU Int. 2008;102(11):1660–1665. doi:10.1111/j.1464-410X.2008.07895.x

24. Hemal AK, Gupta NP, Wadhwa SN, Goel A, Kumar R. Retroperitoneoscopic nephrectomy and nephroureterectomy for benign nonfunctioning kidneys: a single-center experience. Urology. 2001;57(4):644–649. doi:10.1016/s0090-4295(00)01059-1

25. Zhang X, Zheng T, Ma X, et al. Comparison of retroperitoneoscopic nephrectomy versus open approaches to nonfunctioning tuberculous kidneys: a report of 44 cases. J Urol. 2005;173(5):1586–1589. doi:10.1097/01.ju.0000154624.44403.b9

26. Hemal AK, Mishra S. Retroperitoneoscopic nephrectomy for pyonephrotic nonfunctioning kidney. Urology. 2010;75(3):585–588. doi:10.1016/j.urology.2008.07.054

27. Duarte RJ, Mitre AI, Chambô JL, Arap MA, Srougi M. Laparoscopic nephrectomy outside Gerota fascia for management of inflammatory kidney. J Endourol. 2008;22(4):681–686. doi:10.1089/end.2007.0291

28. Manohar T, Desai M, Desai M. Laparoscopic nephrectomy for benign and inflammatory conditions. J Endourol. 2007;21(11):1323–1328. doi:10.1089/end.2007.9883

29. Mejean A, Vogt B, Quazza JE, Chretien Y, Dufour B. Mortality and morbidity after nephrectomy for renal cell carcinoma using a transperitoneal anterior subcostal incision. Eur Urol. 1999;36(4):298–302. doi:10.1159/000020008

30. Lefranc R, Waeckel T, Doerfler A, Tillou X. Emergency nephrectomy in surgical pyelonephritis: outcomes and predictors of conservative management failure. World J Urol. 2025;43(1):561. doi:10.1007/s00345-025-05900-1

31. Olcucuoglu E, Tonyali S, Tastemur S, et al. Comparison of long-term kidney functions after radical nephrectomy and simple nephrectomy. PeerJ. 2019;7:e6701. doi:10.7717/peerj.6701

32. Kasiske BL, Ma JZ, Louis TA, Swan SK. Long-term effects of reduced renal mass in humans. Kidney Int. 1995;48(3):814–819. doi:10.1038/ki.1995.355

33. Katz R, Pode D, Golijanin D, et al. Laparoscopic nephrectomy for infected, obstructed and non-functioning kidneys. Surg Laparosc Endosc Percutan Tech. 2004;14(6):340–343. doi:10.1097/01.sle.0000148466.25814.e1

34. Mosa H, Giannettoni A, Patil K, et al. Pediatric nephrectomy: comparison of perioperative outcomes of three different minimally invasive and open approaches. J Laparoendosc Adv Surg Tech A. 2021;31(12):1466–1470. doi:10.1089/lap.2021.0343

35. Beisland C, Medby PC, Sander S, Beisland HO. Nephrectomy — indications, complications and postoperative mortality in 646 consecutive patients. Eur Urol. 2000;37(1):58–64. doi:10.1159/000020101

36. European Association of Urology. EAU Guidelines on Urological Infections. Genitourinary tuberculosis: surgical treatment, section 3.16.4. Current online guidance accessed September 12, 2026. Guideline.